IL99546A0 - Screening assays - Google Patents

Screening assays

Info

Publication number
IL99546A0
IL99546A0 IL99546A IL9954691A IL99546A0 IL 99546 A0 IL99546 A0 IL 99546A0 IL 99546 A IL99546 A IL 99546A IL 9954691 A IL9954691 A IL 9954691A IL 99546 A0 IL99546 A0 IL 99546A0
Authority
IL
Israel
Prior art keywords
oncoprotein
reporter gene
pct
transcription
sec
Prior art date
Application number
IL99546A
Other languages
English (en)
Original Assignee
Gen Hospital Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gen Hospital Corp filed Critical Gen Hospital Corp
Publication of IL99546A0 publication Critical patent/IL99546A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6897—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Tea And Coffee (AREA)
  • Peptides Or Proteins (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Inspection Of Paper Currency And Valuable Securities (AREA)
  • Catalysts (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Thin Film Transistor (AREA)
  • Light Receiving Elements (AREA)
IL99546A 1990-09-24 1991-09-22 Screening assays IL99546A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US58678190A 1990-09-24 1990-09-24

Publications (1)

Publication Number Publication Date
IL99546A0 true IL99546A0 (en) 1992-08-18

Family

ID=24347091

Family Applications (1)

Application Number Title Priority Date Filing Date
IL99546A IL99546A0 (en) 1990-09-24 1991-09-22 Screening assays

Country Status (19)

Country Link
US (1) US5580721A (de)
EP (1) EP0550592B1 (de)
JP (1) JPH06503713A (de)
KR (1) KR930703462A (de)
CN (1) CN1065092A (de)
AT (1) ATE147793T1 (de)
AU (1) AU650677B2 (de)
CA (1) CA2092000A1 (de)
CZ (1) CZ49693A3 (de)
DE (1) DE69124254T2 (de)
DK (1) DK0550592T3 (de)
FI (1) FI931268L (de)
HU (1) HUT66827A (de)
IE (1) IE913330A1 (de)
IL (1) IL99546A0 (de)
NZ (1) NZ239885A (de)
PT (1) PT99033A (de)
WO (1) WO1992005286A1 (de)
ZA (1) ZA917616B (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5362623A (en) * 1991-06-14 1994-11-08 The John Hopkins University Sequence specific DNA binding by p53
EP0528827B1 (de) * 1990-04-19 1996-09-04 The General Hospital Corporation Screening nach proteinpartnern und deren verwendung
US5322801A (en) * 1990-04-19 1994-06-21 The General Hospital Corporation Protein partner screening assays and uses thereof
DK0593618T3 (da) * 1991-06-27 1998-11-23 Genelabs Tech Inc Screeningsassay til påvisning af DNA-bindende molekyler
HK1004920A1 (en) * 1993-01-21 1998-12-11 President And Fellows Of Harvard College Methods and diagnostic kits utilizing mammalian stress promoters to determine toxicity of a compound
US6824976B1 (en) 1993-04-02 2004-11-30 Rigel Pharmaceuticals, Inc. Method for selective inactivation of viral replication
DE19502584C2 (de) * 1994-01-28 1999-08-12 Medigene Ag Ges Fuer Molekular Verfahren zur Bestimmung der Aktivität eines regulatorischen Faktors sowie Verwendung dieses Verfahrens
US6051373A (en) * 1994-12-07 2000-04-18 Scriptgen Pharmaceuticals, Inc. Methods for screening for inhibitors of the transcription-enhancing activity of the X protein of hepatitis B virus
NZ306767A (en) 1995-04-11 2000-03-27 Univ Johns Hopkins Method of identifying molecular interactions employing counterselection and at least two hybrid molecules or two hybrid systems
US5637463A (en) * 1995-05-04 1997-06-10 Hoffmann-La Roche Inc. Method to detect protein-protein interactions
KR100402836B1 (ko) * 1995-05-11 2004-02-19 주식회사 엘지생명과학 단백질간의상호작용을조절하는물질의새로운탐색시스템
US5569588A (en) * 1995-08-09 1996-10-29 The Regents Of The University Of California Methods for drug screening
US6326140B1 (en) 1995-08-09 2001-12-04 Regents Of The University Of California Systems for generating and analyzing stimulus-response output signal matrices
US5777888A (en) * 1995-08-09 1998-07-07 Regents Of The University Of California Systems for generating and analyzing stimulus-response output signal matrices
US5861249A (en) * 1996-04-23 1999-01-19 Cold Spring Harbor Laboratory Assays and reagents for identifying modulators of cdc25-mediated mitotic activation
US6083693A (en) 1996-06-14 2000-07-04 Curagen Corporation Identification and comparison of protein-protein interactions that occur in populations
US5807708A (en) * 1996-07-30 1998-09-15 Millennium Pharmaceuticals, Inc. Conservin nucleic acid molecules and compositions
US5928888A (en) * 1996-09-26 1999-07-27 Aurora Biosciences Corporation Methods and compositions for sensitive and rapid, functional identification of genomic polynucleotides and secondary screening capabilities
US6623922B1 (en) * 1997-02-14 2003-09-23 Deltagen Proteomics Methods for identifying, characterizing, and evolving cell-type specific CIS regulatory elements
US20040002079A1 (en) * 1998-02-11 2004-01-01 Gunn Robert B. Sodium-phosphate cotransporter in lithium therapy for the treatment of mental illness
WO1999041371A1 (en) 1998-02-13 1999-08-19 Genetrace Systems, Inc. Use of ribozymes for functionating genes
DE60028554T2 (de) 1999-03-23 2007-05-16 Chugai Seiyaku K.K. Verfahren zum screenen nach gegen krebs gerichteten medikamenten
US6689558B2 (en) 2000-02-08 2004-02-10 Sangamo Biosciences, Inc. Cells for drug discovery
WO2003092581A2 (en) * 2001-07-16 2003-11-13 Hk Pharmaceuticals, Inc. Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions
AU2003224674A1 (en) * 2002-03-11 2003-09-29 Hk Pharmaceuticals, Inc. Compounds and methods for analyzing the proteome
US20040086945A1 (en) * 2002-06-03 2004-05-06 The Procter & Gamble Company Hairless protein-interacting partner complexes and methods thereto
WO2004064972A2 (en) * 2003-01-16 2004-08-05 Hk Pharmaceuticals, Inc. Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions
WO2005054870A2 (en) * 2003-11-26 2005-06-16 Vanderbilt University METHODS FOR ASSESSING p19-Arf INTERACTIONS WITH cMyc
CN105802983B (zh) * 2016-03-28 2019-12-03 中国科学院青岛生物能源与过程研究所 一种产脂肪烃基因的高通量筛选方法及获得的突变体与应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4833080A (en) * 1985-12-12 1989-05-23 President And Fellows Of Harvard College Regulation of eucaryotic gene expression
US4981784A (en) * 1987-12-02 1991-01-01 The Salk Institute For Biological Studies Retinoic acid receptor method
US4980281A (en) * 1988-02-10 1990-12-25 Housey Gerard M Method of screening for protein inhibitors and activators
DE68921918T2 (de) * 1988-05-09 1995-09-07 Univ Temple Verfahren zur Voraussage der Wirksamkeit einer antineoplastichen Behandlung bei einzelnen Patienten.
AU7667191A (en) * 1990-04-19 1991-11-11 General Hospital Corporation, The Screening assays for compounds which inhibit the binding of c-myc to dna
WO1992013091A1 (en) * 1991-01-18 1992-08-06 Oncogene Science, Inc. Methods of transcriptionally modulating expression of oncogenes and tumor suppressor genes

Also Published As

Publication number Publication date
FI931268A0 (fi) 1993-03-23
JPH06503713A (ja) 1994-04-28
CZ49693A3 (en) 1994-02-16
CA2092000A1 (en) 1992-03-25
ATE147793T1 (de) 1997-02-15
EP0550592A4 (en) 1994-12-07
ZA917616B (en) 1993-09-24
US5580721A (en) 1996-12-03
EP0550592B1 (de) 1997-01-15
KR930703462A (ko) 1993-11-30
AU650677B2 (en) 1994-06-30
CN1065092A (zh) 1992-10-07
PT99033A (pt) 1992-08-31
DE69124254T2 (de) 1997-06-12
WO1992005286A1 (en) 1992-04-02
DE69124254D1 (de) 1997-02-27
HU9300822D0 (en) 1993-11-29
HUT66827A (en) 1995-01-30
FI931268A7 (fi) 1993-04-21
EP0550592A1 (de) 1993-07-14
IE913330A1 (en) 1992-02-25
FI931268L (fi) 1993-04-21
DK0550592T3 (da) 1997-07-07
AU8627291A (en) 1992-04-15
NZ239885A (en) 1993-07-27

Similar Documents

Publication Publication Date Title
EP0550592A4 (en) Screening assays
FI962879A0 (fi) Sinkkisormiproteiinijohdannaisia ja niiden menetelmiä
WO1995025118A3 (en) Inhibitors of sh2 domain interactions
ATE255125T1 (de) Neue 7-beta-substituierte-4-aza-5-alpha-androstan-3- nen als inhibitoren von 5-alpha-reduktase
BR9609851A (pt) Equipamento para conservação dos dados de produto
FI943260A0 (fi) Vedenkestävä, irrotettava, paineherkkä tarra akryyliemulsiosta
TR199800071T1 (xx) Etiketler ve bu etiketlerin imalat�.
ATE192776T1 (de) Verwendung von fluoreszierenden markierungsmitteln für petroleum- produkte
DE69520589D1 (de) Verwendung einer einkomponentencellulose zur entfernung von tinten, streichmasse und toner aus druckpapier
ATE272606T1 (de) Racemattrennung von ketamin
ATE178410T1 (de) Verfahren zur hochempfindlichen dosierung von herztroponin - i
MX9709360A (es) Metodo para la deteccion de compuestos que modulan los efectos de la proteina de la obesidad.
HK74284A (en) Chromogenic material
NZ335489A (en) Method for the detection of compounds that modulate the effects of the obese (OB) protein
DE3580024D1 (de) Verfahren zum maschinellen auftragen von klebstoff auf buchblockruecken.
DE69229356D1 (de) NEUE VERBESSERUNGEN hinsichtlich der RADIOMARKIERUNG von PROTEINEn
DE69628527D1 (de) Verwendung von metallbeschichtbare Strukturklebstoffe zum Kleben von Kompositen aus Cyanatestern.
ATE178309T1 (de) Verfahren zum unschädlichmachen von herbiziden im getreide unter verwendung von 5-aryloxy-1,2- (disubstituierten) benzolverbindungen
DE69113196D1 (de) Papierzuführvorrichtung zum schnellen Auswechseln von Aufzeichnungsbögen.
DE59702615D1 (de) Vorrichtung zum aufbringen von klebeband auf einen druckzylinder
ATE215019T1 (de) Verfahren zur kennzeichnung von gegenständen
DE69628134D1 (de) Auf der inhibierung von phosphatasen beruhendes verfahren zum nachweis und zur quantifizierung von diarrhoetischem schalentiergift
KR900007629A (ko) 자기발색형 감압기록지용 도공액 조성물
SE8403440D0 (sv) Anordning vid berplocknilngsapparater
DE69729961D1 (de) Inhibitorprotein der dna-gyrase.